Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2019-04-15
2021-06-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Microbiota Pilot Study
NCT03892590
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221
Study of the Intestinal Microbiota
NCT07058961
Microbiota Study in Liver Transplanted Patients
NCT03507140
Implications of the Human Microbiota for Health and Disease
NCT04203303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stable patient
Stable patients who admitted to ICU for observation.
Gut Microbiota
Status of microbiota
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gut Microbiota
Status of microbiota
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Every patients who are admitted to ICU
Exclusion Criteria
* With history of immunosuppressive agents.
* Initial systolic blood pressure \<100
* Initial pulse rate \> 100
* Need emergent operation at brain or torso
* Need vasopressor, transfusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maru Kim
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uijeongbu St.Mary's hospital
Uijeongbu-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maru Kim
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GMPS1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.